Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

EBS

Emergent Biosolutions (EBS)

Emergent Biosolutions Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:EBS
DateTimeSourceHeadlineSymbolCompany
03/21/20194:13PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:EBSEmergent Biosolutions Inc
03/20/201912:08PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NYSE:EBSEmergent Biosolutions Inc
03/19/20196:30AMGlobeNewswire Inc.Emergent BioSolutions Initiates Phase 3 Clinical Study to Evaluate AV7909 for Post-Exposure Prophylaxis of AnthraxNYSE:EBSEmergent Biosolutions Inc
03/13/20195:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:EBSEmergent Biosolutions Inc
03/04/20196:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:EBSEmergent Biosolutions Inc
03/04/20196:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:EBSEmergent Biosolutions Inc
02/28/20194:45PMGlobeNewswire Inc.Emergent BioSolutions Awarded U.S. Department of State Contract to Supply Medical Countermeasures For Chemical Warfare Agents...NYSE:EBSEmergent Biosolutions Inc
02/27/20194:03PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NYSE:EBSEmergent Biosolutions Inc
02/22/20196:05AMEdgar (US Regulatory)Annual Report (10-k)NYSE:EBSEmergent Biosolutions Inc
02/21/20194:24PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:EBSEmergent Biosolutions Inc
02/21/20194:05PMGlobeNewswire Inc.Emergent BioSolutions Reports Fourth Quarter and Full Year 2018 Financial ResultsNYSE:EBSEmergent Biosolutions Inc
02/12/20195:34PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:EBSEmergent Biosolutions Inc
02/12/20196:30AMGlobeNewswire Inc.Emergent BioSolutions Announces Appointment of Seamus Mulligan to its Board of DirectorsNYSE:EBSEmergent Biosolutions Inc
02/11/201911:51AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:EBSEmergent Biosolutions Inc
02/08/20197:15AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:EBSEmergent Biosolutions Inc
02/07/20199:35AMGlobeNewswire Inc.Emergent BioSolutions to Release Fourth Quarter and Full Year 2018 Financial Results and Conduct a Conference Call on Februar...NYSE:EBSEmergent Biosolutions Inc
01/28/20192:55PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:EBSEmergent Biosolutions Inc
01/24/20197:13AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:EBSEmergent Biosolutions Inc
01/24/20197:00AMGlobeNewswire Inc.Emergent BioSolutions Announces Appointment of Robert G. Kramer, Sr. to Its Board of DirectorsNYSE:EBSEmergent Biosolutions Inc
01/07/20196:38AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:EBSEmergent Biosolutions Inc
01/07/20196:30AMGlobeNewswire Inc.Emergent BioSolutions Announces Preliminary 2018 Financial Results and Provides 2019 Financial ForecastNYSE:EBSEmergent Biosolutions Inc
01/04/20197:15AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:EBSEmergent Biosolutions Inc
01/04/20197:00AMGlobeNewswire Inc.Emergent BioSolutions Announces Daniel J. Abdun-Nabi to Retire as CEO; Robert G. Kramer, Sr. to Become President and CEONYSE:EBSEmergent Biosolutions Inc
12/28/20189:01AMGlobeNewswire Inc.Emergent BioSolutions Announces Submission to FDA of Application Covering Emergency Use Authorization for NuThraxâ„¢NYSE:EBSEmergent Biosolutions Inc
12/17/20184:10PMGlobeNewswire Inc.Emergent BioSolutions Receives Health Canada Approval of BioThrax® (Anthrax Vaccine Adsorbed)NYSE:EBSEmergent Biosolutions Inc
12/12/20184:18PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NYSE:EBSEmergent Biosolutions Inc
12/12/20184:18PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NYSE:EBSEmergent Biosolutions Inc
11/29/20184:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:EBSEmergent Biosolutions Inc
11/28/20185:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:EBSEmergent Biosolutions Inc
11/27/20189:27AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NYSE:EBSEmergent Biosolutions Inc
 Showing the most relevant articles for your search:NYSE:EBS